A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis
Clinical trial NCT03972306 · COMPLETED
Trial details
- NCT number
- NCT03972306
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2025-06-03
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.